BTZ043 50 mg | 99.69%
TargetMol
BTZ043 is a DprE1 inhibitor with nanomolar bactericidal activity against Mycobacterium tuberculosis in vitro.
More Information Supplier PageBTZ043
Search Results
BTZ043 10 mg | 99.69%
TargetMol
BTZ043 is a DprE1 inhibitor with nanomolar bactericidal activity against Mycobacterium tuberculosis in vitro.
More Information Supplier PageBTZ043
BTZ043 100 mg | 99.69%
TargetMol
BTZ043 is a DprE1 inhibitor with nanomolar bactericidal activity against Mycobacterium tuberculosis in vitro.
More Information Supplier PageBTZ043
PLX8394 5 mg | 100.00%
TargetMol
PLX8394 is an orally active inhibitor of serine/threonine-protein kinase B-Raf (BRAF) protein. PLX8394 can selectively bind to and inhibit the activity of both wild-type and mutated forms of BRAF, then inhibit the proliferation of tumor cells which express mutated forms of BRAF. PLX8394 appears to be effective against tumors that express multiple mutated forms of […]
More Information Supplier PagePLX8394
PLX8394 50 mg | 100.00%
TargetMol
PLX8394 is an orally active inhibitor of serine/threonine-protein kinase B-Raf (BRAF) protein. PLX8394 can selectively bind to and inhibit the activity of both wild-type and mutated forms of BRAF, then inhibit the proliferation of tumor cells which express mutated forms of BRAF. PLX8394 appears to be effective against tumors that express multiple mutated forms of […]
More Information Supplier PagePLX8394
Resmetirom 10 mg | 99.05%
TargetMol
Resmetirom (VIA-3196) is a highly selective thyroid hormone receptor β (THR-β) agonist.
More Information Supplier PageResmetirom
Resmetirom 1 mg | 99.05%
TargetMol
Resmetirom (VIA-3196) is a highly selective thyroid hormone receptor β (THR-β) agonist.
More Information Supplier PageResmetirom
NVP-BAW2881 50 mg | 98.07%
TargetMol
NVP-BAW2881 (BAW2881) is a potent and selective VEGFR inhibitor (vascular endothelial growth factor receptor tyrosine kinase inhibitor) with activity to inhibit chronic and acute skin inflammation.
More Information Supplier PageNVP-BAW2881
NVP-BAW2881 2 mg | 98.07%
TargetMol
NVP-BAW2881 (BAW2881) is a potent and selective VEGFR inhibitor (vascular endothelial growth factor receptor tyrosine kinase inhibitor) with activity to inhibit chronic and acute skin inflammation.
More Information Supplier PageNVP-BAW2881
NVP-BAW2881 25 mg | 98.07%
TargetMol
NVP-BAW2881 (BAW2881) is a potent and selective VEGFR inhibitor (vascular endothelial growth factor receptor tyrosine kinase inhibitor) with activity to inhibit chronic and acute skin inflammation.
More Information Supplier PageNVP-BAW2881